A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Clinical trial NCT00743769 · WITHDRAWN
Trial details
- NCT number
- NCT00743769
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.